To provide the information your oncologist is not telling you or doesn't have the time to!
Article written by one of our Melanoma/Sarcoma Clinical Trial Coordinators Chloe Caldwell to a target audience of healthcare providers regarding a new ongoing protocol for patients dealing with GIST open globally and at the Orlando Health Cancer Institute. All information posted here is publicly available here. Gastrointestinal Stromal Tumors (GIST) constitute a category of soft …
The instant you hear a cancer diagnosis can be a tremendous emotional whirlwind. Alongside the requisite cancer treatments, it becomes imperative to pay heed to the emotional upheaval that accompanies it. Facing a cancer diagnosis is undeniably a life-transforming event with a profound influence on a person’s emotional health. Acknowledging the prominence of mental health …
Cancer treatment discussions typically revolve around the scientific, procedural, and physical aspects, often side-lining other pivotal components of a patient’s well-being, such as intimacy and sexual health. However, as an oncologist, I’ve come to appreciate the profound impact these aspects have on our overall quality of life and the richness they bring to our human …
In the challenging landscape of cancer, we often talk about treatments such as chemotherapy, radiation, and surgery. Still, there’s another aspect that, while often overlooked, can make a huge difference in the overall well-being of patients – nutrition. Today, I want to take a detour from our usual discussions about clinical trials and treatment strategies …
Oncology, the branch of medicine dedicated to diagnosing and treating cancer, is a realm that thrives on the symbiotic relationship between doctors and patients. In the intricate dance of clinical encounters, oncologists act as guides, illuminating the path with their expertise and experience, while patients embody resilience and courage in their journey towards recovery. This …
Great review article published in the JCO here by Daniel Olson et al. summarizing adoptive cellular therapy for solid tumors and where we are today. I am very excited about solid tumor cellular therapy as we are currently enrolling into solid tumor trials specifically for TIL, PD1 knockout TIL, Neoantigen Selective TIL and TCR MAGE4+ …
ASCO 2023 was an incredible conference and I had completely enjoyed the networking, presentations, and evening meetings. Here are two melanoma clinical trials that we had also participated in enrollment at the Orlando Health Cancer Institute. It is incredibly exciting to see patients do better with improved responses as well as improved odds of not …
ASCO 2023 was a ton of fun and lot of learning. In the coming weeks, I’ll share select abstracts that I thought were most important. This article discusses data from a groundbreaking PROSPECT trial which was presented as a Plenary topic at Chicago and published in NEJM last week. Ultimately, this creates more treatment options …
About the author Dr. Sajeve Thomas is a distinguished medical professional and a compassionate guide in the field of oncology. With over a decade of dedicated experience as a board-certified medical oncologist/internal medicine specialist, Dr. Thomas has become a trusted expert in the treatment of melanoma, sarcoma, and gastrointestinal conditions. Currently practicing at the renowned Orlando …
This video explores the transformative power of Next Generation Sequencing (NGS) in decoding the genetic mysteries of cancer, offering a new era of personalized treatment strategies.